RVMDW
Revolution Medicines, Inc. WarrantNASDAQ
Key Statistics
Market Cap
—
P/E Ratio
—
EPS
—
Beta
1.38
52W High
$10.12
52W Low
$0.16
50-Day MA
$0.00
200-Day MA
$0.00
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Revolution Medicines, Inc. Warrant
Revolution Medicines, Inc., a clinical-stage precision oncology company, develops therapies to inhibit frontier targets in RAS-addicted cancers. The company is headquartered in Redwood City, California.
Fundamentals
| Revenue (TTM) | 742,000 |
| Gross Profit (TTM) | $-1.13B |
| EBITDA | $-1.38B |
| Operating Margin | 0.00% |
| Return on Equity | -76.70% |
| Return on Assets | -37.50% |
| Revenue/Share (TTM) | $0.01 |
| Book Value | $7.49 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | $194.11M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Historical Volatility
HV 10-Day
97.01%
HV 20-Day
74.75%
HV 30-Day
82.98%
HV 60-Day
100.71%
HV Rank
—
Volatility is currently expanding
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on RVMDW and any ticker you trade — then tracks every position and per-strategy win rate.
Data last updated: 7/29/2026